Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease

被引：0

作者：

Hewitt, L. Arthur ^{[1
]}

Ziemann, Adam ^{[1
]}

Biaggioni, Italo ^{[2
]}

Cherny, Katya ^{[1
]}

Vernino, Steven ^{[3
]}

机构：

[1] Lundbeck LLC, Deerfield, IL USA

[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA

[3] UT Southwestern Med Ctr, Dallas, TX USA

来源：

NEUROLOGY | 2017年 / 88卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P5.321

引用

页数：2

共 50 条

[41] Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Fiona Gupta
Beverly Karabin
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 431 - 431
[42] Integrated safety of droxidopa for neurogenic orthostatic hypotension
Kaufmann, H.
Hauser, R. A.
Lisk, J. P.
Szakacs, C. B. N.
MOVEMENT DISORDERS, 2014, 29 : S563 - S564
[43] Integrated efficacy of droxidopa for neurogenic orthostatic hypotension
Hauser, R. A.
Isaacson, S.
Kaufmann, H.
Hewitt, L. A.
MOVEMENT DISORDERS, 2014, 29 : S562 - S562
[44] Impact of droxidopa treatment on falls and fall related injuries in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension (study 306)
Hauser, R. A.
Jerome, L. P.
Schwieterman, W. D.
Cioffi, C. C.
MOVEMENT DISORDERS, 2013, 28 : S171 - S171
[45] Impact of treatment with droxidopa in repeat fallers with Parkinson's disease and symptomatic neurogenic orthostatic hypotension (NOH 306A)
Hauser, R. A.
Schwieterman, W.
Isaacson, S.
MOVEMENT DISORDERS, 2012, 27 : S423 - S423
[46] Effects of Droxidopa Treatment for Neurogenic Orthostatic Hypotension in Patients Concomitantly on Dopa Decarboxylase Inhibitors
Kymes, Steve
Francois, Clement
Sullivan, Christine
McLeod, Kim
Duhig, Amy
Ogbonnaya, Augustina
Quillen, Apryl
Cannon, Joan
Biaggioni, Italo
Shibao, Cyndya A.
Yue, Binglin
Hauser, Robert
NEUROLOGY, 2019, 92 (15)
[47] Effects of Droxidopa Treatment for Neurogenic Orthostatic Hypotension in Patients Concomitantly on Dopa Decarboxylase Inhibitors
Kymes, Steven
Francois, Clement
Sullivan, Christine
McLeod, Kim
Duhig, Amy
Ogbonnaya, Augustina
Quillen, Apryl
Cannon, Joan
Biaggioni, Italo
Shibao, Cyndya
Yue, Binglin
Hauser, Robert
MOVEMENT DISORDERS, 2018, 33 : S69 - S69
[48] Effect of the Initial Maintenance Dose of Droxidopa on Treatment Persistence in Patients With Neurogenic Orthostatic Hypotension
Hewitt, L. Arthur
Amjad, Fahd
Kymes, Steven
Polenchar, Brett
Favit, Antonella
NEUROLOGY, 2021, 96 (15)
[49] Evaluation of droxidopa dosing and clinical response in 50 consecutive patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension
Isaacson, S. H.
Brillman, S.
Chhabria, N.
MOVEMENT DISORDERS, 2016, 31 : S679 - S680
[50] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
Raj, Satish R.
Hewitt, Lawrence Arthur
EUROPEAN HEART JOURNAL, 2019, 40 (01) : 69 - 70

← 1 2 3 4 5 →